Financial News
Articles published by Edgewise Therapeutics
![](https://mms.businesswire.com/media/20230329005975/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20230321005037/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20230314005303/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20230306005065/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20230301005018/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics to Present at the Cowen 43rd Annual Health Care Conference on March 8, 2023
March 01, 2023
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20230228005215/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20230223005253/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20230207005069/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics to Present at the SVB Securities Global Biopharma Conference on February 14, 2023
February 07, 2023
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20230104005249/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023
January 04, 2023
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20221221005112/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics to Showcase Novel Cardiac Program at Virtual Investor Event on Tuesday, January 3, 2023
December 21, 2022
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20221220005213/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20221109005318/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics to Present at Upcoming Investor Conferences
November 09, 2022
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20221103005363/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics Reports Third Quarter 2022 Financial Results
November 03, 2022
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20221027006078/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20221013005743/en/1601418/5/NSAA_and_NSAD_EDG-5506_FINAL.jpg)
![](https://mms.businesswire.com/media/20221006005225/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20220913006310/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
September 13, 2022
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20220912005990/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics Announces Proposed Offering of Common Stock
September 13, 2022
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20220911005054/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20220907005188/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20220803005077/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics to Present at the Wedbush PacGrow Healthcare Conference on August 9
August 03, 2022
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20220712005142/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20220620005099/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20220616005291/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20220531005057/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20220511005067/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20220503005013/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20220414005111/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise-Funded Natural History Trial of Becker Muscular Dystrophy (BMD) Now Enrolling
April 14, 2022
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20220224005267/en/743983/5/Edgewise_Logo_-_JPG.jpg)
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20220202005147/en/743983/5/Edgewise_Logo_-_JPG.jpg)
Edgewise Therapeutics to Participate at SVB Leerink 11th Annual Global Healthcare Conference on February 16
February 02, 2022
Via Business Wire
Tickers
EWTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.